Scarica l'app Stockscreener
2.03
1.46%
-0.03
Pre-mercato:
2.04
0.01
+0.49%
Precedente Chiudi:
$2.06
Aprire:
$2.01
Volume 24 ore:
23,608
Relative Volume:
0.06
Capitalizzazione di mercato:
$5.48M
Reddito:
$832.80K
Utile/perdita netta:
$-21.55M
Rapporto P/E:
-0.1685
EPS:
-12.0465
Flusso di cassa netto:
$-12.71M
1 W Prestazione:
+4.10%
1M Prestazione:
-40.29%
6M Prestazione:
-66.94%
1 anno Prestazione:
-87.92%
Intervallo 1D:
$2.01
$2.1395
Intervallo di 1 settimana:
$1.96
$2.215
Portata 52W:
$1.8401
$41.20
Hcw Biologics Inc Stock (HCWB) Company Profile
Nome
Hcw Biologics Inc
Settore
Industria
Telefono
954-842-2024
Indirizzo
2929 N COMMERCE PKWY, MIRAMAR
Confronta HCWB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
2.03 | 5.57M | 832.80K | -21.55M | -12.71M | -12.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hcw Biologics Inc Borsa (HCWB) Ultime notizie
Will HCW Biologics Inc. stock benefit from sector rotationJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
HCW Biologics Amends License Agreement with Trimmune - MSN
How HCW Biologics Inc. stock performs in rate cut cyclesQuarterly Earnings Report & Real-Time Volume Analysis - Newser
HCW Biologics (NASDAQ:HCWB) Trading Down 7.1% – Here’s What Happened - Defense World
HCW Biologics (HCWB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Hedge Fund Bets: Why HCW Biologics Inc. stock is seen as undervaluedPortfolio Growth Summary & Weekly Chart Analysis and Guides - BỘ NỘI VỤ
Form 8-KCurrent report - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - ADVFN
HCW Biologics Inc. (HCWB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HCW Biologics Secures $4M Through Warrant Exercise - MSN
Why HCW Biologics Inc. stock attracts high net worth investorsMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Is HCW Biologics Inc. stock positioned well for digital economyMarket Movers & Safe Entry Trade Reports - newser.com
Will HCW Biologics Inc. stock benefit from infrastructure spending2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
HCW Biologics Begins Phase 1 Trial for HCW9302 - MSN
[8-K] HCW Biologics Inc. Reports Material Event | HCWB SEC FilingForm 8-K - Stock Titan
Insiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value - simplywall.st
What analysts say about HCW Biologics Inc stockSector Rotation Strategies & Low Risk Trading Growth - earlytimes.in
Why retail investors favor HCW Biologics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
HCW Biologics secures $4 million through warrant exercise agreement By Investing.com - Investing.com Nigeria
HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech - Investing.com Nigeria
Using fundamentals and technicals on HCW Biologics Inc.Market Performance Recap & Real-Time Volume Surge Alerts - newser.com
Hcw Biologics announces warrant inducement agreement - MarketScreener
HCW Biologics secures $4 million through warrant exercise agreement - Investing.com
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules - The Manila Times
HCW Biologics (NASDAQ: HCWB) Announces $4M Warrant Deal, 3,020,410 New Warrants - Stock Titan
HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech By Investing.com - Investing.com South Africa
How HCW Biologics Inc. stock reacts to oil pricesPortfolio Performance Summary & Low Risk Entry Point Guides - newser.com
HCW Biologics doses first patient in alopecia areata clinical trial By Investing.com - Investing.com Nigeria
Hcw Biologics Inc Azioni (HCWB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):